tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Breazzano, 5 are a HOLD (50%), 5 are a BUY (50%).
Analyst Steven Breazzano, carries an average stock price target met ratio of 100% that have a potential upside of 22.51% achieved within 120 days. Previously, Steven Breazzano worked at PIPER SANDLER.
Steven Breazzano’s has documented 21 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 23-Mar-2017.
Analyst best performing recommendations are on MRTX (MIRATI THER).
The best stock recommendation documented was for MRTX (MIRATI THER) at 6/3/2016. The price target of $14 was fulfilled within 3 days with a profit of $4.35 (23.71%) receiving and performance score of 79.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$4
3 years 3 months 24 days ago
(13-Jun-2022)
0/11 (0%)
$2.53 (172.11%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 11 months 5 days ago
(02-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 11 months 2 days ago
(05-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
5 years 2 months 1 days ago
(06-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
5 years 5 months 2 days ago
(05-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
What Year was the first public recommendation made by Steven Breazzano?
